Free Trial
NASDAQ:SRNE

Sorrento Therapeutics (SRNE) Stock Price, News & Analysis

Sorrento Therapeutics logo
$0.0053 +0.00 (+51.43%)
As of 03:40 PM Eastern

About Sorrento Therapeutics Stock (NASDAQ:SRNE)

Key Stats

Today's Range
$0.0036
$0.0097
50-Day Range
N/A
52-Week Range
$0.00
$0.10
Volume
327,908 shs
Average Volume
126,588 shs
Market Capitalization
$2.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sorrento Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
18th Percentile Overall Score

SRNE MarketRank™: 

Sorrento Therapeutics scored higher than 18% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Sorrento Therapeutics.

    • Percentage of Shares Shorted

      0.65% of the float of Sorrento Therapeutics has been sold short.
    • Short Interest Ratio / Days to Cover

      Sorrento Therapeutics has a short interest ratio ("days to cover") of 8.5.
    • Change versus previous month

    • Dividend Yield

      Sorrento Therapeutics does not currently pay a dividend.

    • Dividend Growth

      Sorrento Therapeutics does not have a long track record of dividend growth.

    • Percentage of Shares Shorted

      0.65% of the float of Sorrento Therapeutics has been sold short.
    • Short Interest Ratio / Days to Cover

      Sorrento Therapeutics has a short interest ratio ("days to cover") of 8.5.
    • Change versus previous month

    • Search Interest

      1 people have searched for SRNE on MarketBeat in the last 30 days.
    • MarketBeat Follows

      2 people have added Sorrento Therapeutics to their MarketBeat watchlist in the last 30 days.
    • Insider Buying vs. Insider Selling

      In the past three months, Sorrento Therapeutics insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      Only 2.60% of the stock of Sorrento Therapeutics is held by insiders.

    • Percentage Held by Institutions

      Only 0.02% of the stock of Sorrento Therapeutics is held by institutions.

    • Read more about Sorrento Therapeutics' insider trading history.
    Receive SRNE Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Sorrento Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

    By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

    SRNE Stock News Headlines

    Sorrento Therapeutics Inc (SRNE) - Investing.com
    SRNE Sorrento Therapeutics, Inc. - Seeking Alpha
    Nvidia CEO Makes First Ever Tesla Announcement
    While headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $25 trillion AI revolution — one that Nvidia’s CEO himself has called a “multi-trillion-dollar future industry” — and he’s uncovered a little-known stock 168 times smaller than Nvidia that could be positioned to ride this breakthrough.tc pixel
    Sorrento Therapeutics Inc (SRNE)
    Sorrento Therapeutics Inc SRNE
    See More Headlines

    SRNE Stock Analysis - Frequently Asked Questions

    Sorrento Therapeutics' stock was trading at $0.0005 at the beginning of 2025. Since then, SRNE shares have increased by 1,420.0% and is now trading at $0.0076.

    Shares of SRNE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Sorrento Therapeutics investors own include NIO (NIO), NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Gilead Sciences (GILD), Advanced Micro Devices (AMD) and Johnson & Johnson (JNJ).

    Company Calendar

    Today
    9/16/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    Biological products, except diagnostic
    Sub-Industry
    Pharmaceutical Products
    Current Symbol
    NASDAQ:SRNE
    CIK
    850261
    Employees
    800
    Year Founded
    2006

    Profitability

    EPS (Trailing Twelve Months)
    N/A
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    N/A
    Net Margins
    N/A
    Pretax Margin
    N/A
    Return on Equity
    N/A
    Return on Assets
    N/A

    Debt

    Debt-to-Equity Ratio
    N/A
    Current Ratio
    N/A
    Quick Ratio
    N/A

    Sales & Book Value

    Annual Sales
    $60.32 million
    Price / Sales
    0.03
    Cash Flow
    N/A
    Price / Cash Flow
    N/A
    Book Value
    N/A
    Price / Book
    N/A

    Miscellaneous

    Outstanding Shares
    551,280,000
    Free Float
    536,948,000
    Market Cap
    $1.93 million
    Optionable
    No Data
    Beta
    1.08

    Social Links

    Options Trading Made Easy - Download Now Cover

    Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

    Get This Free Report

    This page (NASDAQ:SRNE) was last updated on 9/16/2025 by MarketBeat.com Staff
    From Our Partners